Article
The Dysregulation of the DLK1-MEG3 Locus in Islets From Patients With Type 2 Diabetes Is Mimicked by Targeted Epimutation of Its Promoter With TALE-DNMT Constructs.
Diabetes - 1 Sept 2018
Kameswaran Vasumathi, Golson Maria L, Ramos-Rodríguez Mireia, Ou Kristy, Wang Yue J, Zhang Jia, Pasquali Lorenzo, Kaestner Klaus H
Abstract excerpt
Type 2 diabetes mellitus (T2DM) is characterized by the inability of the insulin-producing β-cells to overcome insulin resistance. We previously identified an imprinted region on chromosome 14, the DLK1-MEG3 locus, as being downregulated in islets from humans with T2DM. In this study, using targeted epigenetic modifiers, we prove that increased methylation at the promoter of Meg3 in mouse βTC6 β-cells results in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
